Developing a method to study the effect of germline variants and somatic mutations in breast cancer patients on mRNA splicing
Analysis of alternative splicing has provided valuable information for multiple types of cancer, including breast cancer in recent years. Alternative splicing has been suggested to be one of the hallmarks for cancer, as dysregulation of the normal splicing process governs many aspects of cancer cell biology. For several genes previously associated with cancer, specific variants and their effect on